Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sareum (SAR) Regulatory News

Date Source Headline
8th Nov 2018 12:28 pm RNS Sierra Oncology Q3 2018 Results
26th Oct 2018 7:00 am RNS Completion of Placing
1st Oct 2018 7:00 am RNS FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018
27th Sep 2018 1:03 pm RNS Notice of Results
26th Sep 2018 7:00 am RNS TYK2/JAK1 selected for certain cancers
11th Sep 2018 7:00 am RNS Pre-Close Trading Statement
10th Sep 2018 7:00 am RNS Selection of TYK2/JAK1 for autoimmune diseases
9th Aug 2018 1:15 pm RNS Sareum notes Sierra Oncology Q2 2018 Results
11th Jul 2018 9:38 am RNS Notification of PCA Shareholding
15th Jun 2018 7:00 am RNS Advisers
31st May 2018 7:00 am RNS Sareum regains rights to Aurora+FLT3 inhibitors
10th May 2018 12:21 pm RNS SRA737 trial update in Sierra Oncology Q1 Results
24th Apr 2018 7:00 am RNS Sareum to Present at BioTrinity 2018 in London
17th Apr 2018 12:45 pm RNS AACR 2018 Update
15th Mar 2018 7:00 am RNS Late-breaker abstract for SRA737 accepted for AACR
13th Mar 2018 7:00 am RNS Interim Results
27th Feb 2018 12:50 pm RNS Sierra Oncology expands SRA737 development program
22nd Feb 2018 7:00 am RNS Preclinical synergy of sra737 and PARP inhibitor
13th Feb 2018 7:00 am RNS Notice of Interim Results
20th Dec 2017 11:00 am RNS Issue of Options
19th Dec 2017 7:00 am RNS Patent Grants in Japan & China for TYK2 Inhibitors
14th Dec 2017 11:01 am RNS Result of AGM
14th Dec 2017 7:00 am RNS AGM Statement
20th Nov 2017 7:00 am RNS Notice of AGM and Annual Report & Accounts
14th Nov 2017 12:05 pm RNS Placing
31st Oct 2017 7:00 am RNS Sierra Reports Preclinical Data for Chk1 Inhibitor
19th Oct 2017 7:00 am RNS Final Results
9th Oct 2017 12:00 pm RNS Sierra Oncology host KOL Meeting on 12 Oct in NY
18th Sep 2017 12:00 pm RNS Sierra Oncology to host call on Chk1 inhibitor
22nd Aug 2017 7:00 am RNS Pre-Close Trading Statement
19th Jun 2017 7:00 am RNS Sareum to Present at the ICCS 2017
5th Jun 2017 12:13 pm RNS Chk1 Clinical Trials Update
31st May 2017 7:00 am RNS Sierra Oncology Granted US and EU Patents
25th May 2017 7:00 am RNS Sierra Oncology to Present at ASCO Annual Meeting
9th May 2017 7:00 am RNS Sareum to Present at BioTrinity 2017
9th Mar 2017 7:00 am RNS Director Shareholding
20th Feb 2017 7:00 am RNS Half-year Results
9th Feb 2017 7:00 am RNS Notice of Interim Results
9th Jan 2017 12:05 pm RNS Milestone Payment from Chk1 Licence Agreement
22nd Dec 2016 9:47 am RNS Result of General Meeting
FTSE 100 Latest
Value8,054.98
Change-419.76